Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: Prospective evaluation in patients suspected of having pancreatic cancer

Radiology

Volumn 259, Issue 3, 2011, Pages 757-766

  Koelblinger, Claus ^a   Ba Ssalamah, Ahmed ^a   Goetzinger, Peter ^a   Puchner, Stefan ^a   Weber, Michael ^a   Sahora, Klaus ^a   Scharitzer, Martina ^a   Plank, Christina ^a   Schima, Wolfgang ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Herz Jesu Krankenhaus   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; COMPARATIVE EFFECTIVENESS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PANCREAS CANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IOPAMIDOL; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956316944     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101189     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57(1):43-66.
2. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg 2004;91(11):1410-1427. (Pubitemid 39518076)
3. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326(7):455-465.
4. Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997;202(3):655-662. (Pubitemid 27093433)
5. Schima W, Ba-Ssalamah A, Kölblinger C, Kulinna-Cosentini C, Puespoek A, Götzinger P. Pancreatic adenocarcinoma. Eur Radiol 2007; 17(3):638-649.
6. Schima W, Függer R. Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Eur Radiol 2002;12(12):2998-3008. (Pubitemid 36940424)
7. Trede M, Rumstadt B, Wendl K, et al. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann Surg 1997;226(4):393-405, discussion 405-407.
8. Rieber A, Tomczak R, Nüssle K, Klaus H, Brambs HJ. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT. Br J Radiol 2000;73(875):1165-1169.
9. Romijn MG, Stoker J, van Eijck CH, van Muiswinkel JM, Torres CG, Laméris JS. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging 2000;12(2):261-268. (Pubitemid 30612870)
10. Nishiharu T, Yamashita Y, Abe Y, et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging - ROC analysis. Radiology 1999;212(2):445-452. (Pubitemid 29356565)
11. Prokesch RW, Chow LC, Beaulieu CF, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations-initial experience. Radiology 2002;225(3):759-765. (Pubitemid 35387114)
12. Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB Jr. MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 2004;182(2):419-425. (Pubitemid 38116586)
13. Ichikawa T, Erturk SM, Sou H, et al. MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging. AJR Am J Roentgenol 2006;187(6): 1513-1520. (Pubitemid 44788682)
14. Mehmet Erturk S, Ichikawa T, Sou H, et al. Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension. J Comput Assist Tomogr 2006;30(4):583-590. (Pubitemid 44091512)
15. Grenacher L, Klauss M, Dukic L, et al. Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT - a prospective study [in German]. Rofo 2004;176(11):1624-1633. (Pubitemid 39486494)
16. Kauhanen SP, Komar G, Seppänen MP, et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg 2009;250(6):957-963.
17. Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009;30(3):586-595.
18. Edelman RR, Salanitri G, Brand R, et al. Magnetic resonance imaging of the pancreas at 3.0 tesla: qualitative and quantitative comparison with 1.5 tesla. Invest Radiol 2006;41(2):175-180. (Pubitemid 44406215)
19. Schindera ST, Merkle EM, Dale BM, Delong DM, Nelson RC. Abdominal magnetic resonance imaging at 3.0 T: what is the ultimate gain in signal-to-noise ratio? Acad Radiol 2006;13(10):1236-1243.
20. Choi JY, Kim MJ, Chung YE, et al. Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. RadioGraphics 2008;28(4):e30.
21. Runge VM, Biswas J, Wintersperger BJ, et al. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 tesla in brain magnetic resonance imaging: comparison to 1.5 tesla and a standard gadolinium chelate using a rat brain tumor model. Invest Radiol 2006; 41(3):244-248. (Pubitemid 44406184)
22. Kalra MK, Maher MM, Mueller PR, Saini S. State-of-the-art imaging of pancreatic neoplasms. Br J Radiol 2003;76(912):857-865. (Pubitemid 38124509)
23. Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C. State-of-theart magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging 2007; 18(6):421-429. (Pubitemid 351315545)
24. Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr. Isoattenuating pancreatic adenocarcinoma at multidetector row CT: secondary signs. Radiology 2002;224(3):764-768. (Pubitemid 34919810)
25. Ahualli J. The double duct sign. Radiology 2007;244(1):314-315. (Pubitemid 46981990)
26. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thinsection helical CT. AJR Am J Roentgenol 1997;168(6):1439-1443. (Pubitemid 27232661)
27. O'Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol 1999;173(6):1513-1518.
28. Li H, Zeng MS, Zhou KR, Jin DY, Lou WH. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 2005;29(2):170-175. (Pubitemid 40411299)
29. Irie H, Honda H, Kaneko K, Kuroiwa T, Yoshimitsu K, Masuda K. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging 1997;22(4): 429-433. (Pubitemid 27272825)
30. Nakayama Y, Yamashita Y, Kadota M, et al. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assist Tomogr 2001;25(3):337-342. (Pubitemid 32440783)
31. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006;16(6):1337-1345. (Pubitemid 43834721)
32. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 2005;237(1):170-180. (Pubitemid 41346161)